Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection

Journal of Virology

Volumn 74, Issue 13, 2000, Pages 5933-5938

  Meola, Annalisa ^a   Sbardellati, Andrea ^a   Ercole, Bruno Bruni ^a   Cerretani, Mauro ^a   Pezzanera, Monica ^a   Ceccacci, Alessandra ^a   Vitelli, Alessandra ^a   Levy, Shoshana ^b   Nicosia, Alfredo ^a   Traboni, Cinzia ^a   McKeating, Jane ^c   Scarselli, Elisa ^a  

^a IRBM   (Italy)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTHROPOIDEA; ARTICLE; BINDING SITE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HOST CELL; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; BASE SEQUENCE; BINDING SITES; CELL LINE; CLONING, MOLECULAR; DNA, VIRAL; GLYCOPROTEINS; HEPACIVIRUS; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; RECEPTORS, VIRUS; SAGUINUS; SEQUENCE HOMOLOGY, AMINO ACID; SOLUBILITY; TUMOR CELLS, CULTURED; VIRAL ENVELOPE PROTEINS;

EID: 0034122661     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.13.5933-5938.2000     Document Type: Article

References (30)

1. Abe, K., T. Kurata, Y. Teramoto, J. Shiga, and T. Shikata. 1993. Lack of susceptibility of various primates and woodchucks to hepatitis C virus. J. Med. Primatol. 22:433-434.
2. Agnello, V., R. T. Chung, and L. M. Kaplan. 1992. A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med. 327:1490-1495.
3. Alter, M. J. 1997. Epidemiology of hepatitis C. Hepatology 26:62S-65S.
4. Azorsa, D. O., S. Moog, J. Cazenave, and F. Lanza. 1999. A general approach to the generation of monoclonal antibodies against members of the tetraspanin superfamily using recombinant GST fusion proteins. J. Immunol. Methods 229:35-48.
5. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
6. Choo, Q. L., A. J. Weiner, L. R. Overby, G. Kuo, M. Houghton, and D. W. Bradley. 1990. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br. Med. Bull. 46:423-441.
7. Doms, R. W., and S. C. Peiper. 1997. Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology 235:179-190.
8. Donnelly, J. J., D. Martinez, K. U. Jansen, R. W. Ellis, D. L. Montgomery, and M. A. Liu. 1996. Protection against papillomavirus with a polynucleotide vaccine. J. Infect. Dis. 173:314-320.
9. Flint, M., C. Maidens, L. D. Loomis-Price, C. Shotton, J. Dubuisson, P. Monk, A. Higginbottom, S. Levy, and J. A. McKeating. 1999. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 73:6235-6244.
10. Flint, M., J. M. Thomas, C. M. Maidens, C. Shotton, S. Levy, W. S. Barclay, and J. A. McKeating. 1999. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J. Virol. 73:6782-6790.
11. Garson, J. A., K. Whitby, P. Watkins, and A. J. Morgan. 1997. Lack of susceptibility of the cottontop tamarin to hepatitis C infection. J. Med. Virol. 52:286-288.
12. Higginbottom, A., E. R. Quinn, C. C. Kuo, M. Flint, L. Wilson, E. Bianchi, A. Nicosia, P. N. Monk, J. McKeating, and S. Levy. 2000. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein. J. Virol. 74:3642-3649.
13. Levy, S., S. C. Todd, and H. T. Maecker. 1998. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16:89-109.
14. Maecker, H. T., S. C. Todd, and S. Levy. 1997. The tetraspanin superfamily: molecular facilitators. FASEB J. 11:428-442.
15. Matsuura, Y., T. Suzuki, R. Suzuki, M. Sato, H. Aizaki, I. Saito, and T. Miyamura. 1994. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology 205:141-150.
16. Michalak, J. P., C. Wychowski, A. Choukhi, J. C. Meunier, S. Ung, C. M. Rice, and J. Dubuisson. 1997. Characterization of truncated forms of hepatitis C virus glycoproteins. J. Gen. Virol. 78:2299-2306.
17. Moore, J. P., A. Trkola, and T. Dragic. 1997. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9:551-562.
18. Neddermann, P., L. Tomei, C. Steinkuhler, P. Gallinari, A. Tramontano, and R. De Francesco. 1997. The nonstructural proteins of the hepatitis C virus: structure and functions. Biol. Chem. 378:469-476.
19. Pileri, P., Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A. J. Weiner, M. Houghton, D. Rosa, G. Grandi, and S. Abrignani. 1998. Binding of hepatitis C virus to CD81. Science 282:938-941.
20. Rice, C. M. 1996. Flaviviridae: the virus and their replication, p. 931-959. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
21. Rice, C. M. 1999. Is CD81 the key to hepatitis C virus entry? Hepatology 29:990-992.
22. Rosa, D., S. Campagnoli, C. Moretto, E. Guenzi, L. Cousens, M. Chin, C. Dong, A. J. Weiner, J. Y. Lau, Q. L. Choo, D. Chien, P. Pileri, M. Houghton, and S. Abrignani. 1996. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc. Natl. Acad. Sci. USA 93:1759-1763.
23. Rubinstein, E., F. Le Naour, C. Lagaudriere-Gesbert, M. Billard, H. Conjeaud, and C. Boucheix. 1996. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur. J. Immunol. 26:2657-2665.
24. Saito, I., T. Miyaraura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Y. Ohta, et al. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87:6547-6549.
25. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
26. Sato, S., A. S. Miller, M. C. Howard, and T. F. Tedder. 1997. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J. Immunol. 159:3278-3287.
27. Selby, M. J., E. Glazer, F. Masiarz, and M. Houghton. 1994. Complex processing and protein:protein interactions in the E2:NS2 region of HCV. Virology 204:114-122.
28. Spaete, R. R., D. Alexander, M. E. Rugroden, Q. L. Choo, K. Berger, K. Crawford, C. Kuo, S. Leng, C. Lee, R. Ralston, et al. 1992. Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology 188:819-830.
29. Szollosi, J., V. Horejsi, L. Bene, P. Angelisova, and S. Damjanovich. 1996. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J. Immunol. 157:2939-2946.
30. van Doorn, L. J. 1994. Review: molecular biology of the hepatitis C virus. J. Med. Virol. 43:345-356.